Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

2.050

-0.070 (-3.30%)

At close: Nov 20, 2024, 4:00 PM

2.070

+0.020 (0.98%)

After-hours: Nov 20, 2024, 7:24 PM EST

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $429.83 million as of November 21, 2024. Its market cap has decreased by -22.13% in one year.

Market Cap

429.83M

Enterprise Value

230.79M

1-Year Change

-22.13%

Ranking

#3119

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $429.83M, a decrease of -85.08%. That is a compound annual growth rate of -26.74%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	429.83M	-20.43%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	3.17B	-3.19%
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SIGA Technologies	446.28M
Pacific Biosciences of California	445.03M
Xeris Biopharma Holdings	437.55M
National Research	437.12M
Korro Bio	436.48M
Foghorn Therapeutics	432.79M
Quanterix	431.76M
Aquestive Therapeutics	428.54M

Market Cap Rankings